James L. Reading
- Immunology top 5%
- Immunotherapy and Immune Responses 7
- Immune Cell Function and Interaction 4
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 6
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 4
- Genetics top 10%
- Mesenchymal stem cell research 3
-
- HIV Research and Treatment 3
-
- Bladder and Urothelial Cancer Treatments 3
- Co-authors
- Charles SwantonSergio A. QuezadaNicholas McGranahanRachel RosenthalKevin LitchfieldHang XuSamra TurajlicJames Larkin
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Nature Communications (2 papers)Frontiers in Immunology (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
James L. Reading
28 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Immunology 543
- Oncology 698
- Cancer Research 263
- Genetics 96
- Pulmonary and Respiratory Medicine 272
Countries citing papers authored by James L. Reading
This map shows the geographic impact of James L. Reading's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Reading with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Reading more than expected).
Fields of papers citing papers by James L. Reading
This network shows the impact of papers produced by James L. Reading. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Reading. The network helps show where James L. Reading may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James L. Reading, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 16 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 1 | |
| 7 | 2020 | 68 | |
| 8 | 2020 | 3 | |
| 9 | 2020 | 5 | |
| 10 | HLA-C restricted neoepitopes contribute significantly to the immune recognition of cancer | 2019 | 1 |
| 11 | 2018 | 13 | |
| 12 | 2017 | 96 | |
| 13 | Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysisbreakdown → | 2017 | 662 |
| 14 | 2015 | 35 | |
| 15 | 2013 | 56 | |
| 16 | 2012 | 6 | |
| 17 | 2011 | 12 | |
| 18 | TRANSVERSE INCISION FOR LESSER METATARSOPHALANGEAL EXPOSURE. A WORKHORSE INCISION FOR THE FOREFOOT | 2005 | 0 |
| 19 | 1995 | 37 | |
| 20 | 1995 | 56 |
About James L. Reading
James L. Reading is a scholar working on Virology, Immunology and Oncology, having authored 29 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (7 papers), CAR-T cell therapy research (6 papers), Immune Cell Function and Interaction (4 papers), Cancer Genomics and Diagnostics (4 papers), HIV Research and Treatment (3 papers), Mesenchymal stem cell research (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). The work is most often cited by research in Immunology (543 citations), Oncology (698 citations) and Cancer Research (263 citations). James L. Reading has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Charles Swanton, Sergio A. Quezada, Nicholas McGranahan, Rachel Rosenthal, Kevin Litchfield, Hang Xu, Samra Turajlic, James Larkin, Andrew Rowan and Yien Ning Sophia Wong. Their work appears in journals such as Nature Communications, Frontiers in Immunology, Annals of Oncology, Journal of Clinical Oncology and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.